article thumbnail

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

She also sought input on overlapping aspects of community practice across the disciplines of internal medicine to inform ABIM’s recruitment efforts for broad physician representation in governance roles. The group discussed evolving trends in telehealth and how to capture that as a category of community practice.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

She also sought input on overlapping aspects of community practice across the disciplines of internal medicine to inform ABIM’s recruitment efforts for broad physician representation in governance roles. The group discussed how sharing data of this kind between organizations is a step toward a solution.

article thumbnail

Plenary Abstracts at AAHPM/HPNA: Yael Schenker, Na Ouyang, Marie Bakitas

GeriPal

But again, hindsight’s 2020 probably wasn’t the best measure to look the other one we tested in an exploratory way was feeling heard and understood. Marie 17:38 So this is a moving target right now because the, you know, the emergency pandemic telehealth regulations that were waived have sunsetted as of January 1st.